HCID 86722457, compound → HCID 86722454, compound
Reaction equation
[Br:1][C:2]1[C:10]2[N:9]([C:11]3[CH:16]=[CH:15][C:14]([F:17])=[CH:13][CH:12]=3)[N:8]=[CH:7][C:6]=2[CH:5]=[C:4]2[C@@:18]3([CH:32]=[CH2:33])[CH2:26][CH2:25][C@:24]([C:28]([F:31])([F:30])[F:29])([OH:27])[CH2:23][C@@H:19]3[CH2:20][CH2:21][O:22][C:3]=12.[Br:34][C:35]1[C:43]2[N:42]([C:44]3[CH:49]=[CH:48][C:47]([F:50])=[CH:46][CH:45]=3)[N:41]=[CH:40][C:39]=2[CH:38]=[C:37]2[C@:51]3([CH:65]=[CH2:66])[CH2:59][CH2:58][C@@:57]([C:61]([F:64])([F:63])[F:62])([OH:60])[CH2:56][C@H:52]3[CH2:53][CH2:54][O:55][C:36]=12>[Pd].C1COCC1>[Br:1][C:2]1[C:10]2[N:9]([C:11]3[CH:12]=[CH:13][C:14]([F:17])=[CH:15][CH:16]=3)[N:8]=[CH:7][C:6]=2[CH:5]=[C:4]2[C@@:18]3([CH2:32][CH3:33])[CH2:26][CH2:25][C@:24]([C:28]([F:29])([F:31])[F:30])([OH:27])[CH2:23][C@@H:19]3[CH2:20][CH2:21][O:22][C:3]=12.[Br:34][C:35]1[C:43]2[N:42]([C:44]3[CH:45]=[CH:46][C:47]([F:50])=[CH:48][CH:49]=3)[N:41]=[CH:40][C:39]=2[CH:38]=[C:37]2[C@:51]3([CH2:65][CH3:66])[CH2:59][CH2:58][C@@:57]([C:61]([F:62])([F:64])[F:63])([OH:60])[CH2:56][C@H:52]3[CH2:53][CH2:54][O:55][C:36]=12Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
To 10% Pd/C (wet, 0.162 g) was added a solution of (3R,4aR,12bS)-8-bromo-9-(4-fluorophenyl)-3-(trifluoromethyl)-12b-vinyl-2,3,4,4a,5,6,9,12b-octahydro-1H-benzo[4,5]oxepino[3,2-f]indazol-3-ol; compound with (3S,4aS,12bR)-8-bromo-9-(4-fluorophenyl)-3-(trifluoromethyl)-12b-vinyl-2,3,4,4a,5,6,9,12b-octahydro-1H-benzo[4,5]oxepino[3,2-f]indazol-3-ol (107, R1=4-Fluorophenyl, R2=Vinyl, R3=Trifluoromethyl) (0.443 g, 0.843 mmol) and THF (8.0 mL). The mixture was placed under an hydrogen atmosphere using a balloon. After about 4 h, the hydrogen atmosphere was evacuated and the mixture was filtered through Celite® rinsing with THF (50 mL). The volatiles were removed under reduced pressure. The residue was purified on silica gel (24 g) using a gradient of 0-5% EtOAc in DCM. The fractions containing the product were combined and concentrated under reduced pressure to afford (3R,4aR,12bR)-8-bromo-12b-ethyl-9-(4-fluorophenyl)-3-(trifluoromethyl)-2,3,4,4a,5,6,9,12b-octahydro-1H-benzo[4,5]oxepino[3,2-f]indazol-3-ol; compound with (3S,4aS,12bS)-8-bromo-12b-ethyl-9-(4-fluorophenyl)-3-(trifluoromethyl)-2,3,4,4a,5,6,9,12b-octahydro-1H-benzo[4,5]oxepino[3,2-f]indazol-3-ol (108, R1=4-Fluorophenyl, R2=Ethyl, R3=Trifluoromethyl) (0.410 g, 92% yield) as an ivory solid. LC/MS, method 3, Rt=2.63 min, MS m/z 527 and 529 (M+H)+. 1H NMR (400 MHz, DMSO) δ 8.29 (s, 1H), 7.81 (s, 1H), 7.58-7.51 (m, 2H), 7.39-7.29 (m, 2H), 5.92 (s, 1H), 4.47-4.38 (m, 1H), 3.48-3.38 (m, 1H), 2.41-2.28 (m, 1H), 2.25-1.51 (m, 10H), 0.41 (t, J=7.3 Hz, 3H).
Workup
- customthe hydrogen atmosphere was evacuated
- filtrationthe mixture was filtered through Celite®
- washrinsing with THF (50 mL)
- customThe volatiles were removed under reduced pressure
- customThe residue was purified on silica gel (24 g)
- additionThe fractions containing the product
- concentrationconcentrated under reduced pressure
Sources & evidence
- ORD record
- ord-d6b6e85256e34356be96850c5d4740ca
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09193744B2
Reaction notes
Loading…